Lawrence L Rudel

Pyripyropene A, an Acyl–Coenzyme A: Cholesterol Acyltransferase 2–Selective Inhibitor, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia

Hiroshi Tomoda, Satoshi Omura, S. Ōmura, 2011, Arteriosclerosis, thrombosis, and vascular biology.

ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver

Mats Eriksson, Hiroshi Tomoda, Satoshi Omura, 2004, Circulation.

Inhibition of Acyl-Coenzyme A:Cholesterol Acyltransferase 2 (ACAT2) Prevents Dietary Cholesterol-associated Steatosis by Enhancing Hepatic Triglyceride Mobilization*

M. Willingham, Heather M. Alger, J. M. Brown, 2010, The Journal of Biological Chemistry.

Selective Inhibition of Acyl-CoA:cholesterol Acyltransferase 2 Isozyme by Flavasperone and Sterigmatocystin from Aspergillus Species

Hiroshi Tomoda, S. Ohte, L. Rudel, 2008, The Journal of Antibiotics.

Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness.

Hiroshi Tomoda, Satoshi Omura, S. Ōmura, 2004, Journal of lipid research.

Selectivity of Pyripyropene Derivatives in Inhibition toward Acyl-CoA:cholesterol Acyltransferase 2 Isozyme

Hiroshi Tomoda, Toshiaki Sunazuka, S. Ōmura, 2008, The Journal of Antibiotics.

Dietary Monounsaturated Fatty Acids Appear Not to Provide Cardioprotection

L. Rudel, C. Degirolamo, Chiara Degirolamo, 2010, Current atherosclerosis reports.

Selectivity of Microbial Acyl-CoA : cholesterol Acyltransferase Inhibitors toward Isozymes

Hiroshi Tomoda, S. Ōmura, L. Rudel, 2007, The Journal of Antibiotics.

Targeted Depletion of Hepatic ACAT2-driven Cholesterol Esterification Reveals a Non-biliary Route for Fecal Neutral Sterol Loss*

Thomas L. Smith, Mark J Graham, Richard G. Lee, 2008, Journal of Biological Chemistry.